The Patent Finder

Ascendis Pharma A/S

Also on record
Records under this name other than the patents Ascendis Pharma A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 41 patents it holds.

Back to Ascendis Pharma A/S

PatentTitleStatus Expires Confidence
US 7,879,588Protein-proteophore complexes
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,098,930PEGylated Recombinant Human Growth Hormone Compounds
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,960,053PEGylated recombinant human growth hormone compounds
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,919,033Dry growth hormone composition transiently linked to a polymer carrier
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,682,395Dry growth hormone composition transiently linked to a polymer carrier
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,062,094Dipeptide-based prodrug linkers for aliphatic amine-containing drugs
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,226,457Dry growth hormone composition transiently linked to a polymer carrier
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,272,048PEGylated recombinant human growth hormone compounds
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,561,287Carrier-linked treprostinil prodrugs
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,511,122Dry growth hormone composition transiently linked to a polymer carrier
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 25 patents shown.
Pro members see all 25.
Pro members: see all 25 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited